Empower Your Team With Early Cancer Risk Insight
Forward-thinking employers use Health Savings Accounts (HSAs) to invest in meaningful wellness benefits including proactive cancer risk assessment through miRoncol.
Why It Matters
Cancer remains the leading cause of lost productivity and medical cost in the workplace. Yet, most cancers are still detected only after symptoms appear.
By integrating miRoncol’s Real-time Multi-Cancer Early Risk Assessment into your company’s wellness program, you can help employees take a proactive step in understanding their current biological cancer risk — using funds already available in their HSA accounts.
For Employers & HR Leaders
Offering preventive tools like miRoncol demonstrates a tangible commitment to employee well-being and long-term health.
Key Benefits:
Adds Value to Existing Benefits
Employees can use HSA funds for the miRoncol Early Risk Assessment, reinforcing your company’s prevention-first culture.
Supports Early Action
Helps employees detect cancer-like molecular signals sooner, leading to more timely medical evaluation.
Promotes Health Literacy
Encourages evidence-based health discussions between staff and their physicians.
Improves Employee Satisfaction
Wellness benefits that go beyond gym memberships and routine check-ups resonate with a modern, proactive workforce.
For Employees
The miRoncol test provides a blood-based early cancer risk assessment identifying molecular signals associated with common solid tumours such as lung, breast, prostate, colorectal, and pancreatic cancers.
- Accessible through participating clinics
- Reviewed directly with a healthcare provider
- Complements, not replaces, existing screening programs
Integration Ideas for Employers
- Include miRoncol in annual wellness checkups or executive health packages
- Offer partial or full HSA reimbursement for staff who choose testing
- Highlight in your company’s open enrollment or wellness communications
- Partner with miRoncol to co-brand educational materials for internal health campaigns
Why This Matters for the Future of Workplace Health
Early detection is no longer limited to hospital-based screening. As precision medicine moves into preventive health, molecular pre-screening tools like miRoncol help close the gap between prevention and diagnosis.
By encouraging your employees to participate, your organization becomes part of the shift toward real-time, proactive health monitoring where prevention is an act of empowerment.
Your Next Step
If you manage health benefits or oversee an employee wellness program:
